Peptosyl

Peptosyl may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Peptosyl

Bentonite

Bentonite is reported as an ingredient of Peptosyl in the following countries:

• New Zealand

Bismuth Subsalicylate

Bismuth Subsalicylate is reported as an ingredient of Peptosyl in the following countries:

• Australia


• New Zealand

International Drug Name Search

Klacid Hp7

Klacid Hp7 may be available in the countries listed below.

Ingredient matches for Klacid Hp7

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Klacid Hp7 in the following countries:

• Australia

Clarithromycin

Clarithromycin is reported as an ingredient of Klacid Hp7 in the following countries:

• Australia

Omeprazole

Omeprazole is reported as an ingredient of Klacid Hp7 in the following countries:

• Australia

International Drug Name Search

Micardis HCT

Micardis HCT is a brand name of hydrochlorothiazide/telmisartan, approved by the FDA in the following formulation(s):

MICARDIS HCT (hydrochlorothiazide; telmisartan - tablet; oral)

• 
  Manufacturer: BOEHRINGER INGELHEIM
  
  Approval date: November 17, 2000
  
  Strength(s): 12.5MG;40MG, 12.5MG;80MG
  


• 
  Manufacturer: BOEHRINGER INGELHEIM
  
  Approval date: April 19, 2004
  
  Strength(s): 25MG;80MG ^[RLD]

Has a generic version of Micardis HCT been approved?

No. There is currently no therapeutically equivalent version of Micardis HCT available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Micardis HCT. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Benzimidazoles useful as angiotensin-11 antagonists
  Patent 5,591,762
  Issued: January 7, 1997
  Inventor(s): Hauel; Norbert & Narr, deceased; Berthold & Ries; Uwe & van Meel; Jacobus C. A. & Wienen; Wolfgang & Entzeroth; Michael
  Assignee(s): Dr. Karl Thomae GmbH
  Disclosed herein are angiotensin-II antagonists of the formula ##STR1## wherein R.sub.1 is, other than hydrogen and, inter alia, halogen, lower alkyl or cycloalkyl; R.sub.2 is, inter alia, optionally substituted benzimidazol-2-yl, 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-yl, butanesultam-1-yl, imidazol-4-yl, and tetrahydobenzimidazol-2-yl; R.sub.3 is, inter alia, lower alkyl; and, R.sub.4 is an acidic group, such as carboxyl or tetrazolyl. An exemplary compound is: (a) 4'-[[2-n-propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)-benzimidazol-1-yl] methyl]-biphenyl-2-carboxylic acid.
  
  Patent expiration dates:
  
  
  • January 7, 2014
    
    ✓ 
    Patent use: TREATMENT OF HYPERTENSION
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  



• 
  Polymorphs of telmisartan
  Patent 6,358,986
  Issued: March 19, 2002
  Inventor(s): Heinrich; Schneider
  Assignee(s): Boehringer Ingelheim Pharma KG
  The invention relates to polymorphs of 4′-[2-n-propyl-4-methyl-6-(1-methylbenzimid-azol-2-yl)benzimidazol-1-ylmethyl]biphenyl-2-carboxylic acid (INN: telmisartan), particularly polymorphic form B, mixtures of the polymorphs, processes for preparing telmisartan containing form B and the use thereof for preparing a pharmaceutical composition.
  
  Patent expiration dates:
  
  
  • January 10, 2020
    
  
  

See also...

• Micardis HCT Consumer Information (Wolters Kluwer)
• Micardis HCT Consumer Information (Cerner Multum)
• Micardis HCT Advanced Consumer Information (Micromedex)
• Hydrochlorothiazide/Telmisartan Consumer Information (Wolters Kluwer)
• Hydrochlorothiazide and telmisartan Consumer Information (Cerner Multum)
• Telmisartan and hydrochlorothiazide Advanced Consumer Information (Micromedex)

Ticoflex

Ticoflex may be available in the countries listed below.

Ingredient matches for Ticoflex

Naproxen

Naproxen is reported as an ingredient of Ticoflex in the following countries:

• Bangladesh

International Drug Name Search

Metrima

Metrima may be available in the countries listed below.

Ingredient matches for Metrima

Clotrimazole

Clotrimazole is reported as an ingredient of Metrima in the following countries:

• Vietnam

International Drug Name Search

Zemlon

Zemlon may be available in the countries listed below.

Ingredient matches for Zemlon

Sodium Alginate Sulfate

Sodium Alginate Sulfate is reported as an ingredient of Zemlon in the following countries:

• Japan

International Drug Name Search

Kenalog-40

See also: Generic Kenalog-10

Kenalog-40 is a brand name of triamcinolone, approved by the FDA in the following formulation(s):

KENALOG-40 (triamcinolone acetonide - injectable; injection)

• 
  Manufacturer: APOTHECON
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 40MG/ML ^[RLD][AB]

Has a generic version of Kenalog-40 been approved?

Yes. The following products are equivalent to Kenalog-40:

triamcinolone acetonide injectable; injection

• 
  Manufacturer: SANDOZ
  
  Approval date: May 27, 2009
  
  Strength(s): 40MG/ML ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Kenalog-40. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Kenalog-40.

See also...

• Kenalog-40 Suspension Consumer Information (Wolters Kluwer)
• Kenalog-40 injection Consumer Information (Cerner Multum)
• Kenalog-40 Advanced Consumer Information (Micromedex)
• Triamcinolone Consumer Information (Drugs.com)
• Triamcinolone Consumer Information (Wolters Kluwer)
• Triamcinolone Aerosol Consumer Information (Wolters Kluwer)
• Triamcinolone Suspension Consumer Information (Wolters Kluwer)
• Triamcinolone Consumer Information (Cerner Multum)
• Triamcinolone inhalation Consumer Information (Cerner Multum)
• Triamcinolone injection Consumer Information (Cerner Multum)
• Triesense Advanced Consumer Information (Micromedex)
• Triamcinolone Injection Advanced Consumer Information (Micromedex)
• Triamcinolone AHFS DI Monographs (ASHP)
• Triamcinolone Acetonide AHFS DI Monographs (ASHP)
• Triamcinolone Hexacetonide AHFS DI Monographs (ASHP)

Batroxobina

Batroxobina may be available in the countries listed below.

Ingredient matches for Batroxobina

Batroxobin

Batroxobina (DCIT) is also known as Batroxobin (Rec.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.